Wealth Enhancement Advisory Services’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $74.9M | Buy |
3,158,575
+462,844
| +17% | +$12.1M | 0.13% | 143 |
|
|
2026
Q1 | $75M | Sell |
2,695,731
-718,817
| -21% | -$19.1M | 0.15% | 123 |
|
|
2025
Q4 | $86.8M | Buy |
3,414,548
+105,368
| +3% | +$2.66M | 0.12% | 157 |
|
|
2025
Q3 | $86.9M | Buy |
3,309,180
+223,460
| +7% | +$5.52M | 0.13% | 150 |
|
|
2025
Q2 | $78.3M | Buy |
3,085,720
+479,597
| +18% | +$11.2M | 0.13% | 156 |
|
|
2025
Q1 | $66M | Buy |
2,606,123
+929,680
| +55% | +$24.3M | 0.13% | 159 |
|
|
2024
Q4 | $44.5M | Buy |
1,676,443
+151,865
| +10% | +$4.12M | 0.09% | 221 |
|
|
2024
Q3 | $44.1M | Sell |
1,524,578
-124,233
| -8% | -$3.62M | 0.09% | 208 |
|
|
2024
Q2 | $46.1M | Buy |
1,648,811
+21,970
| +1% | +$605K | 0.11% | 187 |
|
|
2024
Q1 | $45.1M | Sell |
1,626,841
-206,117
| -11% | -$5.72M | 0.12% | 176 |
|
|
2023
Q4 | $52.8M | Buy |
1,832,958
+55,819
| +3% | +$1.69M | 0.15% | 144 |
|
|
2023
Q3 | $58.9M | Buy |
1,777,139
+1,474,649
| +488% | +$52.1M | 0.19% | 116 |
|
|
2023
Q2 | $11.1M | Sell |
302,490
-2,977
| -1% | -$116K | 0.12% | 83 |
|
|
2023
Q1 | $12.5M | Buy |
305,467
+100,281
| +49% | +$4.33M | 0.15% | 76 |
|
|
2022
Q4 | $8.94M | Buy |
205,186
+72,375
| +54% | +$3.47M | 0.12% | 89 |
|
|
2022
Q3 | $5.62M | Sell |
132,811
-9,509
| -7% | -$462K | 0.08% | 114 |
|
|
2022
Q2 | $7.57M | Buy |
142,320
+78,953
| +125% | +$4.02M | 0.11% | 97 |
|
|
2022
Q1 | $3.23M | Sell |
63,367
-2,359
| -4% | -$122K | 0.04% | 162 |
|
|
2021
Q4 | $3.46M | Buy |
65,726
+50,944
| +345% | +$2.52M | 0.05% | 139 |
|
|
2021
Q3 | $644K | Sell |
14,782
-51,508
| -78% | -$2.28M | 0.01% | 236 |
|
|
2021
Q2 | $2.66M | Buy |
66,290
+51,686
| +354% | +$2.01M | 0.04% | 135 |
|
|
2021
Q1 | $526K | Buy |
+14,604
| New | +$519K | 0.01% | 228 |
|
|
2020
Q3 | – | Sell |
-142,811
| Closed | -$5.22M | – | 234 |
|
|
2020
Q2 | $5.22M | Buy |
+142,811
| New | +$4.85M | 0.15% | 56 |
|
|
2020
Q1 | – | Sell |
-5,469
| Closed | -$203K | – | 261 |
|
|
2019
Q4 | $203K | Sell |
5,469
-61,351
| -92% | -$2.19M | 0.01% | 204 |
|
|
2019
Q3 | $2.29M | Buy |
66,820
+4,903
| +8% | +$178K | 0.09% | 89 |
|
|
2019
Q2 | $2.44M | Sell |
61,917
-36,153
| -37% | -$1.44M | 0.11% | 80 |
|
|
2019
Q1 | $3.67M | Sell |
98,070
-9,726
| -9% | -$390K | 0.21% | 44 |
|
|
2018
Q4 | $4.35M | Buy |
+107,796
| New | +$4.47M | 0.27% | 40 |
|
|
2018
Q2 | – | Sell |
-122,866
| Closed | -$4.24M | – | 187 |
|
|
2018
Q1 | $4.24M | Buy |
122,866
+61,882
| +101% | +$2.13M | 0.28% | 40 |
|
|
2017
Q4 | $2.11M | Buy |
+60,984
| New | +$2.08M | 0.15% | 75 |
|
|
2016
Q4 | – | Sell |
-76,010
| Closed | -$2.44M | – | 173 |
|
|
2016
Q3 | $2.44M | Buy |
+76,010
| New | +$2.54M | 0.36% | 45 |
|
Other funds holding PFE
Wealth Enhancement Advisory Services's PFE Position: Q2 2026 in Review
Wealth Enhancement Advisory Services increased its Pfizer (PFE) stake by 17% in Q2 2026, buying an estimated $12.1M and bringing the position to 3,158,575 shares worth $74.9M. The position accounts for 0.13% of the portfolio, ranked #143.
Wealth Enhancement Advisory Services first reported a position in PFE in Q3 2016 and has held it in 31 quarters since. The position peaked at $86.9M in Q3 2025. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Wealth Enhancement Advisory Services held 3,158,575 shares of Pfizer worth $74.9M as of Q2 2026.
- Wealth Enhancement Advisory Services bought 462,844 Pfizer shares in Q2 2026, an estimated $12.1M.
- Pfizer made up 0.13% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #143 holding.
- Wealth Enhancement Advisory Services first reported a position in Pfizer in Q3 2016 and has held it in 31 quarters since.
- Wealth Enhancement Advisory Services's Pfizer position peaked at $86.9M in Q3 2025.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.